Waive
PrivateLast Round
Accelerator
Mar 10, 2026
Total Funding Raised
$10,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Waive is a healthtech company that provides intelligent automation tools for medical clinics to streamline administrative tasks, manage patient communication, and automate paperwork.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Workflow Automation, Patient Engagement, Medical AI, Document Management
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Waive Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Waive Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 10, 2026 | ||||
| VC Round | Apr 9, 2024 | ||||
| Seed | Oct 16, 2023 | ||||
| Accelerator | Aug 20, 2020 |
Waive Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dunin-Deshpande Queen's Innovation Centre | Accelerator |
| Ripple Ventures | Seed |
| Northern Ontario Angels | Seed |
| Google for Startups Accelerator | Accelerator |
| Enactus Canada | Accelerator |
| Transform VC | Seed |
| Archangel Network of Funds | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 26, 2026
Grew 33% QoQ from 12 to 16 employees.
- Apr 15, 2026
Monthly visitors increased 689% MoM, reaching 15.2K.
Waive Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Waive's valuation, stock price, and market status.